NCT00606801View on ClinicalTrials.gov

Galantamine Effects on Cognitive Function in Abstinent Cocaine Users

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Cocaine Abuse
Interventions
DRUG

Galantamine

Galantamine 8 mg/day

DRUG

placebo

sugar pill

Trial Locations (1)

06516

Veterans Affairs Hospital, West Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT00606801 - Galantamine Effects on Cognitive Function in Abstinent Cocaine Users | Biotech Hunter | Biotech Hunter